The size of the Remote Patient Monitoring Market in Europe was worth USD 1046 Million in 2020 and is estimated to be growing at a CAGR of 13.52%, to reach USD 1972 Million by 2025. Europe accounts for the second-largest market share in the global market.
Taking healthcare home is an evolving drift in the healthcare industry amidst increasing concerns over the geriatric population and costs sustained in people enduring chronic illness. The eminence and benefits of remote patient monitoring technology are making it progressively attractive to vendors all over the continent. Remote patient monitoring has the ability to modify the way patients handle their own conditions so that they come to be the keepers of their own healthcare.
Healthcare schemes in Europe are strained due to an elderly population and a growing number of chronic disease patients. This triggers tremendous cost pressures to swing from acute care situations to lower-cost settings, comprising a patient’s home.
These are a few factors driving the Remote patient monitoring market. The major limitations are the unsteady and uneven reimbursement strategies in this region.
This research report on the European Remote Patient Monitoring market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End-Use:
By Country:
The increasing occurrence of diabetes is a major factor that is predicted to increase the demand for hematology monitoring devices in the global remote patient monitoring devices market.
In recent years, the U.K. has advanced extensively in remote patient monitoring, which is estimated to increase the market in terms of value.
The market contributors are involved in mergers and attainments and new product enhancement to preserve sustainability.
Key players operating in the Europe Remote Patient Monitoring Systems Market profiled in this report are Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc, Honeywell, American Telecare, Biotronik, and Covidien Plc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Breath Monitors
5.1.2 Physical Activity Monitors
5.1.3 Heart Monitors
5.1.4 Haematological Monitors
5.1.5 Multi-Sign Monitors
5.2 By Application
5.2.1 Cancer Treatment
5.2.2 Cardiovascular Diseases
5.2.3 Diabetes Treatment
5.2.4 Sleep Disorder
5.2.5 Weight Management and Fitness Monitoring
5.3 By End-Use
5.3.1 Hospitals
5.3.2 Ambulatory Care Centers
5.3.3 Home Healthcare
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Welch Allyn
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Bosch
8.3 Johnson & Johnson
8.4 Intel
8.5 Roche
8.6 Philips Healthcare
8.7 Philips
8.8 Healthanywhere Inc
8.9 Honeywell
8.10 American Telecare
8.11 Biotronik
8.12 Covidien Plc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
